NeuroSigma

About:

NeuroSigma develops and commercializes trigeminal nerve stimulation (TNS) for a variety of neurologic and psychiatric disorders.

Website: http://neurosigma.com

Twitter/X: neurosigma

Top Investors: KT Corp

Description:

NeuroSigma, Inc. is a medical device company based in Westwood, California. NeuroSigma is focused on commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments targeting epilepsy, depression, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD). NeuroSigma is actively engaged in cutting-edge preclinical research and development, as well as groundbreaking Phase I, II, & III clinical trials.